HIMS
Hims & Hers Health, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
28.77
close · 2026-08-13
value
14
cheaper than peers14
quality
17
stronger fundamentals17
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 3.10× | 44 |
| price to book | 20.71× | 19 |
| EV to EBITDA | 92.22× | 17 |
| forward P/E | 22.81× | 17 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | -2.7% | 48 |
| revenue growth | 3.8% | 36 |
| debt to equity | 253.7% | 26 |
| operating margin | -7.9% | 25 |
4 of 4 measures available
Facts
| market cap | $7B |
| free cash flow | $174.3M |
| employees | 2,442 |
| first trade | 2019-09-13 |
| next earnings | 2026-08-10 |
| fundamentals updated | 2026-08-10 |